deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT02797548

Perioperative Antiplatelet Therapy in Patients With Drug-eluting Stent Undergoing Noncardiac Surgery (ASSURE-DES)

Sponsor: CardioVascular Research Foundation, Korea

Updated 21 times since 2017 Last updated: Nov 4, 2024 Started: Mar 16, 2017 Primary completion: May 31, 2024 Completion: May 31, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Antiplatelet Drugs and is currently completed. CardioVascular Research Foundation, Korea leads this study, which shows 21 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Mar 2017 · 28 days · monthly snapshot~Mar 2017 – ~Jul 2017 · 4 months · monthly snapshot~Jul 2017 – ~Jun 2018 · 11 months · monthly snapshot~Jun 2018 – ~Dec 2018 · 6 months · monthly snapshot~Dec 2018 – ~Dec 2019 · 12 months · monthly snapshot~Dec 2019 – ~Jun 2020 · 6 months · monthly snapshot~Jun 2020 – ~Jul 2020 · 30 days · monthly snapshot~Jul 2020 – ~Jan 2021 · 6 months · monthly snapshot~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshot~Apr 2021 – ~Oct 2021 · 6 months · monthly snapshot~Oct 2021 – ~Jan 2023 · 15 months · monthly snapshot~Jan 2023 – ~Mar 2023 · 59 days · monthly snapshot~Mar 2023 – ~Jan 2024 · 10 months · monthly snapshot~Jan 2024 – ~Apr 2024 · 3 months · monthly snapshot~Apr 2024 – ~Jun 2024 · 2 months · monthly snapshot~Jun 2024 – ~Jul 2024 · 30 days · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Dec 2024 · 3 months · monthly snapshot~Dec 2024 – ~Sep 2025 · 9 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

21 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed PHASE4

  2. Dec 2024 — Sep 2025 [monthly]

    Completed PHASE4

    Status: Active Not RecruitingCompleted

  3. Sep 2024 — Dec 2024 [monthly]

    Active Not Recruiting PHASE4

  4. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE4

  5. Jun 2024 — Jul 2024 [monthly]

    Active Not Recruiting PHASE4

    Status: RecruitingActive Not Recruiting

Show 16 earlier versions
  1. Apr 2024 — Jun 2024 [monthly]

    Recruiting PHASE4

  2. Jan 2024 — Apr 2024 [monthly]

    Recruiting PHASE4

  3. Mar 2023 — Jan 2024 [monthly]

    Recruiting PHASE4

  4. Jan 2023 — Mar 2023 [monthly]

    Recruiting PHASE4

  5. Oct 2021 — Jan 2023 [monthly]

    Recruiting PHASE4

  6. Apr 2021 — Oct 2021 [monthly]

    Recruiting PHASE4

  7. Jan 2021 — Apr 2021 [monthly]

    Recruiting PHASE4

  8. Jul 2020 — Jan 2021 [monthly]

    Recruiting PHASE4

  9. Jun 2020 — Jul 2020 [monthly]

    Recruiting PHASE4

  10. Dec 2019 — Jun 2020 [monthly]

    Recruiting PHASE4

  11. Dec 2018 — Dec 2019 [monthly]

    Recruiting PHASE4

  12. Jun 2018 — Dec 2018 [monthly]

    Recruiting PHASE4

  13. Jul 2017 — Jun 2018 [monthly]

    Recruiting PHASE4

    Status: Not Yet RecruitingRecruiting

  14. Mar 2017 — Jul 2017 [monthly]

    Not Yet Recruiting PHASE4

  15. Feb 2017 — Mar 2017 [monthly]

    Not Yet Recruiting PHASE4

  16. Jan 2017 — Feb 2017 [monthly]

    Not Yet Recruiting PHASE4

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • CardioVascular Research Foundation, Korea
  • Jung-min Ahn
Data source: Asan Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .